Welcome to Bio.News
We partnered with the Biotechnology Innovation Organization (BIO) in 2019 to develop comprehensive news content about the industry and a quick-read daily newsletter with […]
Welcome to Bio.News Read More »
Get BIO’s view on everything from health care to biofuels and the bioeconomy. The below articles include BIO statements, opinion, and calls to action, as well as articles and op-eds written by BIO leadership.
We partnered with the Biotechnology Innovation Organization (BIO) in 2019 to develop comprehensive news content about the industry and a quick-read daily newsletter with […]
Welcome to Bio.News Read More »
Democrats filed a proposal for drug price controls with the Senate Parliamentarian on Wednesday, seeking to classify the bill as “budget reconciliation,” so it
Senate Democrats move forward on drug price controls Read More »
In comments to the U.S. Department of Agriculture (USDA) Animal and Plant Health Inspection Service (APHIS), the biotech sector suggests the agency needs to
BIO: APHIS strategy needs regulatory clarity to boost innovation Read More »
The House Appropriations Committee is set to mark up today the fiscal year 2023 spending bill for Health and Human Services (HHS), which would
Healthcare spending bill draft includes many BIO requests Read More »
The Bayh-Dole Act was meant to encourage innovative research. However, some lawmakers are trying to change the intent of the law using the “march-in
‘Backdoor’ drug price controls will limit access to medicines, says expert Read More »
The FDA’s Accelerated Approval pathway has assisted America’s biotech industry in making remarkable advances over the last 30 years—but it has come under political
Accelerated Approval is under political attack, experts say Read More »
On April 13, the U.S. Food and Drug Administration (FDA) released new draft guidance for industry on “creating strategies to recruit additional participants from underrepresented
BIO recommends improvements to FDA’s clinical trial diversity guidance Read More »
On June 22, the Senate Commerce Committee approved BIO-supported legislation intended to increase transparency of the business practices of pharmacy benefit managers (PBMs), which
Senate Committee advances PBM transparency legislation Read More »
The Biotechnology Innovation Organization (BIO) is proud to celebrate Pride Month, which, in many places, is returning to in-person celebrations for the first time
Pride Month is back in person – here’s how biotech is celebrating Read More »
The World Trade Organization (WTO) agreed to waive COVID vaccine intellectual property protections—and many stakeholders are upset about it. Yes, the COVID vaccine IP
The COVID vaccine IP waiver is not a good idea – here’s why Read More »